000795.SZ
Innuovo Technology Co., Ltd. [000795.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000795.SZ Stock Summary
Top 10 Correlated ETFs
000795.SZ
Top 10 Correlated Stocks
000795.SZ
In the News
000795.SZ Financial details
Company Rating
Strong Buy
Market Cap
6.64B
Income
86.71M
Revenue
3.85B
Book val./share
2.35
Cash/share
1.09
Dividend
0.08
Dividend %
1.38%
Employees
4.69K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2021
P/E
50.21
Forward P/E
-
PEG
-7.58
P/S
1.7
P/B
2.46
P/C
5.33
P/FCF
18.58
Quick Ratio
0.98
Current Ratio
1.74
Debt / Equity
0.28
LT Debt / Equity
0.01
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-66.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.78%
Revenue last 5Y
8.82%
Revenue Q/Q
9.43%
EPS Q/Q
-82.76%
-
-
-
-
SMA20
-
SMA50
20%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
5%
ROC
0.06%
Gross Margin
17%
Oper. Margin
4%
Profit Margin
3%
Payout
92%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.94-8.18
52W High
-27.38%
52W Low
+93.67%
RSI
55
Rel Volume
0.72
Avg Volume
13.95M
Volume
9.99M
Perf Week
-5.07%
Perf Month
11.09%
Perf Quarter
-3.01%
Perf Half Y
-7.04%
-
-
-
-
Beta
-0.399
-
-
Volatility
0.16%, 0.22%
Prev Close
0%
Price
5.81
Change
4.5%
000795.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.22 | 2.29 | 3.32 | 4.19 | 3.43 | |
| Net income per share | 0.13 | 0.07 | 0.09 | 0.23 | 0.08 | |
| Operating cash flow per share | 0.24 | 0.12 | -0.11 | 0.06 | 0.4 | |
| Free cash flow per share | 0.1 | 0.02 | -0.24 | -0.06 | 0.32 | |
| Cash per share | 0.49 | 0.8 | 0.42 | 0.84 | 1.09 | |
| Book value per share | 2.03 | 2.06 | 2.18 | 2.39 | 2.35 | |
| Tangible book value per share | 1.96 | 2 | 2.11 | 2.3 | 2.29 | |
| Share holders equity per share | 2.03 | 2.06 | 2.18 | 2.39 | 2.35 | |
| Interest debt per share | 0.21 | 0.53 | 0.42 | 1.14 | 0.68 | |
| Market cap | 6.9B | 6.2B | 9.69B | 7.34B | 6.95B | |
| Enterprise value | 6.56B | 5.87B | 9.81B | 7.75B | 6.89B | |
| P/E ratio | 48.44 | 83.67 | 98.99 | 28.38 | 80.2 | |
| Price to sales ratio | 2.75 | 2.38 | 2.58 | 1.55 | 1.81 | |
| POCF ratio | 25.83 | 44.29 | -74.76 | 113.16 | 15.48 | |
| PFCF ratio | 59.26 | 326.16 | -35.1 | -100.51 | 19.33 | |
| P/B Ratio | 3 | 2.65 | 3.92 | 2.72 | 2.65 | |
| PTB ratio | 3 | 2.65 | 3.92 | 2.72 | 2.65 | |
| EV to sales | 2.61 | 2.26 | 2.61 | 1.64 | 1.8 | |
| Enterprise value over EBITDA | 21.84 | 23.86 | 32.26 | 15.27 | 31.71 | |
| EV to operating cash flow | 24.56 | 41.93 | -75.67 | 119.53 | 15.34 | |
| EV to free cash flow | 56.34 | 308.82 | -35.53 | -106.17 | 19.15 | |
| Earnings yield | 0.02 | 0.01 | 0.01 | 0.04 | 0.01 | |
| Free cash flow yield | 0.02 | 0 | -0.03 | -0.01 | 0.05 | |
| Debt to equity | 0.1 | 0.25 | 0.18 | 0.46 | 0.28 | |
| Debt to assets | 0.07 | 0.15 | 0.1 | 0.25 | 0.17 | |
| Net debt to EBITDA | -1.13 | -1.34 | 0.39 | 0.81 | -0.3 | |
| Current ratio | 2.52 | 2 | 1.82 | 1.87 | 2.13 | |
| Interest coverage | 16.71 | 9.73 | 5.95 | 10.5 | 3.4 | |
| Income quality | 1.82 | 1.89 | -1.32 | 0.27 | 5.18 | |
| Dividend Yield | 0 | 0.01 | 0 | 0 | 0.01 | |
| Payout ratio | 0.08 | 0.44 | 0.11 | 0.09 | 1.03 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | -0.56 | -0.86 | 1.13 | -2.13 | -0.2 | |
| Capex to revenue | -0.06 | -0.05 | -0.04 | -0.03 | -0.02 | |
| Capex to depreciation | -1.59 | -1.36 | -1.3 | -1.32 | -0.83 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | -0.05 | |
| Graham number | 2.39 | 1.74 | 2.06 | 3.51 | 2.03 | |
| ROIC | 0.06 | 0.05 | 0.05 | 0.09 | 0.03 | |
| Return on tangible assets | 0.04 | 0.02 | 0.02 | 0.05 | 0.02 | |
| Graham Net | 0.44 | 0.4 | -0.03 | 0.21 | 0.85 | |
| Working capital | 1.51B | 1.48B | 1.56B | 1.83B | 1.68B | |
| Tangible asset value | 2.24B | 2.27B | 2.39B | 2.6B | 2.56B | |
| Net current asset value | 1.44B | 1.42B | 1.5B | 1.69B | 1.66B | |
| Invested capital | 0.1 | 0.25 | 0.18 | 0.46 | 0.28 | |
| Average receivables | 836.87M | 958.47M | 1.05B | 1.26B | 1.26B | |
| Average payables | 478.13M | 638.62M | 941.56M | 911.94M | 566.23M | |
| Average inventory | 531.78M | 648.75M | 947.98M | 1.06B | 853.19M | |
| Days sales outstanding | 138.82 | 134.89 | 111.07 | 106.76 | 108.53 | |
| Days payables outstanding | 107.33 | 117.66 | 137.21 | 59.53 | 57.55 | |
| Days of inventory on hand | 104.74 | 123.53 | 134.72 | 88.99 | 87.57 | |
| Receivables turnover | 2.63 | 2.71 | 3.29 | 3.42 | 3.36 | |
| Payables turnover | 3.4 | 3.1 | 2.66 | 6.13 | 6.34 | |
| Inventory turnover | 3.48 | 2.95 | 2.71 | 4.1 | 4.17 | |
| ROE | 0.06 | 0.03 | 0.04 | 0.1 | 0.03 | |
| Capex per share | -0.13 | -0.11 | -0.13 | -0.12 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.05 | 0.75 | 0.92 | 0.84 | 0.92 | |
| Net income per share | 0.04 | 0.03 | 0.02 | 0.02 | 0 | |
| Operating cash flow per share | 0.04 | 0.03 | 0.32 | 0.01 | 0.08 | |
| Free cash flow per share | 0.02 | 0 | 0.31 | 0 | 0.06 | |
| Cash per share | 0.85 | 0.85 | 1.05 | 1.07 | 1.09 | |
| Book value per share | 2.41 | 2.45 | 2.34 | 2.37 | 2.35 | |
| Tangible book value per share | 2.32 | 2.36 | 2.26 | 2.29 | 2.29 | |
| Share holders equity per share | 2.41 | 2.45 | 2.34 | 2.37 | 2.35 | |
| Interest debt per share | 1.12 | 1.26 | 1.32 | 1.24 | 0.66 | |
| Market cap | 7.26B | 7.51B | 8.48B | 6.99B | 6.95B | |
| Enterprise value | 7.68B | 8.18B | 9B | 7.29B | 6.89B | |
| P/E ratio | 38.2 | 48.44 | 120.13 | 67.51 | 392.99 | |
| Price to sales ratio | 6.17 | 8.91 | 8.25 | 7.41 | 6.74 | |
| POCF ratio | 152.81 | 193.74 | 23.64 | 513.44 | 74.82 | |
| PFCF ratio | 426.93 | 2.16K | 24.64 | 5.18K | 105.84 | |
| P/B Ratio | 2.69 | 2.74 | 3.24 | 2.64 | 2.65 | |
| PTB ratio | 2.69 | 2.74 | 3.24 | 2.64 | 2.65 | |
| EV to sales | 6.52 | 9.7 | 8.75 | 7.73 | 6.68 | |
| Enterprise value over EBITDA | 128.44 | 147.2 | 113.18 | 121.83 | 84.48 | |
| EV to operating cash flow | 161.5 | 211.06 | 25.08 | 535.75 | 74.12 | |
| EV to free cash flow | 451.2 | 2.36K | 26.14 | 5.41K | 104.85 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0.04 | 0 | 0.01 | |
| Debt to equity | 0.46 | 0.51 | 0.56 | 0.52 | 0.28 | |
| Debt to assets | 0.25 | 0.28 | 0.29 | 0.27 | 0.17 | |
| Net debt to EBITDA | 6.91 | 12.07 | 6.5 | 5.07 | -0.8 | |
| Current ratio | 1.87 | 1.89 | 1.79 | 1.74 | 2.13 | |
| Interest coverage | 40.77 | 6.42 | 2.72 | 5.67 | 10.29 | |
| Income quality | 1 | 1 | 20.33 | 0.53 | 21.01 | |
| Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
| Payout ratio | 0.01 | 0.17 | 5.79 | 0.42 | 2.74 | |
| Sales general and administrative to revenue | -0.1 | 0.05 | -0.02 | 0.1 | -0.07 | |
| Research and developement to revenue | 0.04 | 0.06 | 0.05 | 0.04 | 0.03 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | |
| Capex to operating cash flow | -0.64 | -0.91 | -0.04 | -0.9 | -0.29 | |
| Capex to revenue | -0.03 | -0.04 | -0.01 | -0.01 | -0.03 | |
| Capex to depreciation | -1.55 | -1.33 | -0.55 | 0.24 | -1 | |
| Stock based compensation to revenue | 0.07 | 0 | 0 | 0 | 0 | |
| Graham number | 1.52 | 1.38 | 0.91 | 1.11 | 0.46 | |
| ROIC | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Return on tangible assets | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Graham Net | 0.21 | 0.12 | 0.08 | 0.03 | 0.85 | |
| Working capital | 1.83B | 1.87B | 1.81B | 1.75B | 1.68B | |
| Tangible asset value | 2.6B | 2.64B | 2.53B | 2.56B | 2.56B | |
| Net current asset value | 1.69B | 1.73B | 1.65B | 1.67B | 1.66B | |
| Invested capital | 0.46 | 0.51 | 0.56 | 0.52 | 0.28 | |
| Average receivables | 1.43B | 1.33B | 1.27B | 1.19B | 1.13B | |
| Average payables | 775.32M | 605.63M | 641.57M | 719.11M | 618.37M | |
| Average inventory | 982.34M | 946.38M | 901.2M | 856.68M | 811.68M | |
| Days sales outstanding | 105.74 | 136.57 | 110.23 | 106.86 | 99.41 | |
| Days payables outstanding | 58.67 | 76.28 | 72.59 | 83.75 | 55.65 | |
| Days of inventory on hand | 87.71 | 124.82 | 88.1 | 97.99 | 84.68 | |
| Receivables turnover | 0.85 | 0.66 | 0.82 | 0.84 | 0.91 | |
| Payables turnover | 1.53 | 1.18 | 1.24 | 1.07 | 1.62 | |
| Inventory turnover | 1.03 | 0.72 | 1.02 | 0.92 | 1.06 | |
| ROE | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex per share | -0.03 | -0.03 | -0.01 | -0.01 | -0.02 |
000795.SZ Frequently Asked Questions
What is Innuovo Technology Co., Ltd. stock symbol ?
Innuovo Technology Co., Ltd. is a CN stock and trading under the symbol 000795.SZ
What is Innuovo Technology Co., Ltd. stock quote today ?
Innuovo Technology Co., Ltd. stock price is $5.81 today.
Is Innuovo Technology Co., Ltd. stock public?
Yes, Innuovo Technology Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 13.95M
- Market Capitalization 6.64B
- Employee 4.69K
- CEO Mr. Zhonghua Wei
- Headquarters Jinhua,CN
- IPO Date 1997-08-08
-
Website
https://www.innuovo.com 
Innuovo Technology Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of rare earth permanent magnet materials in China. The company was formerly known as Taiyuan Shuangta Ganyu Co., Ltd. Innuovo Technology Co., Ltd. was founded in 1997 and is based in Jinhua, China.
